{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:50:50Z","timestamp":1792795850181,"version":"4.5.0"},"reference-count":114,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Graduate Studies and Research, Ajman University","award":["2017-A-PH-03"],"award-info":[{"award-number":["2017-A-PH-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Pharmacological and Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,3,5]]},"abstract":"<jats:p>Chemotherapeutics can induce oxidative stress, inflammation, apoptosis, mitochondrial dysfunction, and abnormalities in neurotransmitter metabolism leading to toxicity. Because there have been no therapeutic strategies developed to target inflammation and oxidative stress, there is a continuing need for new and improved therapy. As a result, there has been increasing interest in complementary and alternative medicine with anticancer potential. Studies have shown that the antioxidant activities and anti-inflammatory effects of citrus fruits are promising natural phytochemicals in the development of new anticancer agents. Tangeretin is a naturally polymethoxylated flavone compound extracted from the citrus peel that has shown significant intestinal absorption and adequate bioavailability, with the added benefit of promoting longevity. In addition, tangeretin is known to exhibit considerable selective toxicity to many types of cancer cell proliferation such as ovarian, brain, blood, and skin cancer. Evidence indicates that tangeretin acts through several mechanisms including growth inhibition, induction of apoptosis, autophagy, antiangiogenesis, and estrogenic-like effects. Furthermore, tangeretin works through mitigating levels of inflammatory mediators in the immune system. Using tangeretin in combination with clinically applied anticancer drugs could be a good strategy for increasing the efficiency of these agents and protecting noncancerous cells from damage caused by chemotherapy. The purpose of this review is to highlight the protective effects of a novel natural product, tangeretin against chemotherapeutic-induced toxicity. The development of chemoprevention strategies can lead to significant health care improvement in cancer survivors. Thus, study outcomes may attract more investigators to conduct tangeretin-related research and find out potentially significant impacts on health care of cancer patients and decreased health problems associated with chemotherapeutics-induced toxicity.<\/jats:p>","DOI":"10.1155\/2021\/4709818","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:51:31Z","timestamp":1614973891000},"page":"1-15","source":"Crossref","is-referenced-by-count":20,"title":["Therapeutic Implications of a Polymethoxylated Flavone, Tangeretin, in the Management of Cancer via Modulation of Different Molecular Pathways"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-6624","authenticated-orcid":true,"given":"El-Shaimaa A.","family":"Arafa","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE"},{"name":"Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, UAE"},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-6627","authenticated-orcid":true,"given":"Noura T.","family":"Shurrab","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-1698","authenticated-orcid":true,"given":"Manal A.","family":"Buabeid","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, UAE"},{"name":"Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012592.pub2"},{"issue":"2","key":"2","first-page":"389","article-title":"Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin","volume":"4","author":"E. Mechetner","year":"1998","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto960112.x"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00294102"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.5672"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2014.864418"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.4103\/0973-7847.134247"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019473"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020401"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2012.13.2.427"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.03.169"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2018.04.001"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2014.01.007"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.03.013"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2011.01.024"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-016-9657-x"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151649"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.01.011"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-017-0394-4"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-016-1207-z"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20175991"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-119074"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5b03482"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301988"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.56.60"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1021\/jf1044475"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.3390\/nu9090973"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200112040-00053"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2629-z"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.10.1677"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1543"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3034"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.11.017"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.11.3186S"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201701157R"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2014.06.845"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.8b01875"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-380866-0.60009-5"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-957864"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x1701200108"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1016\/s1383-5718(99)00010-8"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.11.016"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2223"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.63.896"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.518"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030921"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2018.06.073"},{"issue":"4","key":"48","first-page":"1532","article-title":"Inhibition of cancer cell growth by Tangeretin flavone in drug-resistant MDA-MB-231 human breast carcinoma cells is facilitated via targeting cell apoptosis, cell cycle phase distribution, cell invasion and activation of numerous caspases","volume":"24","author":"S. Fan","year":"2019","journal-title":"Journal of the Balkan Union of Oncology"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2008.01.058"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041388"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.02.073"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246140"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2014.2818"},{"issue":"1B","key":"54","first-page":"735","article-title":"Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery","volume":"26","author":"M. Glaeser","year":"2006","journal-title":"Anticancer Research"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1016\/s1535-6108(04)00059-5"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000223064.62762.0b"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-011-0078-2"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1078\/0171-9335-00190"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1016\/0012-1606(89)90283-2"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.3390\/ph11010007"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2014-0076"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.60965"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00563"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-6915(01)00058-8"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.039"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2018.32010.7691"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.09.008"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1021\/jf035354z"},{"issue":"1","key":"69","first-page":"103","article-title":"A safety study of oral tangeretin and xanthohumol administration to laboratory mice","volume":"19","author":"B. W. Vanhoecke","year":"2005","journal-title":"Vivo"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2015.04.031"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-6915(02)00007-8"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2016.11.021"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2020.126578"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00051-1"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.02.010"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.08.007"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-016-0140-1"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.105756"},{"key":"79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.09.018"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.7307"},{"key":"81","doi-asserted-by":"publisher","DOI":"10.3109\/07357900902744486"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(00)00549-8"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi1947.116.3_244"},{"key":"84","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00088-4"},{"key":"85","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x1501000304"},{"key":"86","doi-asserted-by":"publisher","DOI":"10.1021\/jf103204x"},{"key":"87","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200204000-00001"},{"key":"88","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199210000-00013"},{"key":"89","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(91)90089-z"},{"key":"90","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3388-0"},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2402515"},{"key":"92","doi-asserted-by":"publisher","DOI":"10.1046\/j.0305-1846.2000.00298.x"},{"key":"93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2014.06.007"},{"key":"94","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(00)00234-3"},{"key":"95","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.30.20150060"},{"key":"96","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(97)04664-8"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1080\/01635589609514482"},{"key":"98","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1412473"},{"key":"99","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107"},{"key":"100","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M500140-MCP200"},{"key":"101","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2007.05.002"},{"key":"102","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2009.156"},{"key":"103","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204981"},{"key":"104","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2010.63"},{"key":"105","doi-asserted-by":"publisher","DOI":"10.14670\/HH-20.1121"},{"key":"106","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2006.0215"},{"key":"107","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-004-1212-8"},{"key":"108","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2264"},{"key":"109","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2006.0214"},{"key":"110","doi-asserted-by":"publisher","DOI":"10.1023\/B:BREA.0000020991.55659.59"},{"issue":"2","key":"111","first-page":"493","article-title":"Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells","volume":"11","author":"A. K. Tyagi","year":"2004","journal-title":"Oncology Reports"},{"key":"112","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2007.01.010"},{"key":"113","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.4.354"},{"key":"114","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.04.003"}],"container-title":["Advances in Pharmacological and Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/aps\/2021\/4709818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/aps\/2021\/4709818.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/aps\/2021\/4709818.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:51:45Z","timestamp":1614973905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/aps\/2021\/4709818\/"}},"subtitle":[],"editor":[{"given":"Benedetto","family":"Natalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":114,"alternative-id":["4709818","4709818"],"URL":"https:\/\/doi.org\/10.1155\/2021\/4709818","relation":{},"ISSN":["2633-4690","2633-4682"],"issn-type":[{"value":"2633-4690","type":"electronic"},{"value":"2633-4682","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,5]]}}}